Alpha Cognition (XCNQ:ACOG) Net Change in Cash : C$-1.91 Mil (TTM As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Alpha Cognition Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Alpha Cognition's Net Change in Cash for the three months ended in Mar. 2024 was C$1.26 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 was C$-1.91 Mil.

Alpha Cognition Net Change in Cash Historical Data

The historical data trend for Alpha Cognition's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alpha Cognition Net Change in Cash Chart

Alpha Cognition Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Net Change in Cash

0.55

6.88

-12.52

-0.79

Alpha Cognition Quarterly Data
	Jan20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Change in Cash	Get a 7-Day Free Trial										2.46	-3.53	-0.42	0.79	1.26

Alpha Cognition Net Change in Cash Calculation

Alpha Cognition's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-11.711	+	0	+	10.946	+	-0.027
	=	-0.79

Alpha Cognition's Net Change in Cash for the quarter that ended in Mar. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -3.323 + 0 + 4.579 + 0

= 1.26

Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-1.91 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alpha Cognition Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Alpha Cognition's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Alpha Cognition (XCNQ:ACOG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alpha Cognition Inc (XCNQ:ACOG) » Definitions » Net Change in Cash

Comparable Companies

TSXV:TTI TSXV:COV TSX:TH TSX:APS TSXV:CZO XCNQ:GLAB TSXV:IBT TSX:ATE TSXV:GSD XCNQ:DOSE OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX

Traded in Other Exchanges

ACOGF:USA

Address

301 - 1228 Hamilton Street, Vancouver, BC, CAN, V6B 6L2

Website

https://www.alphacognition.com

Alpha Cognition Inc is a clinical stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, and Cognitive Impairment with Mild Traumatic Brain Injury (mTBI) for which there are limited or no treatment options. The Company is focused on the development of ALPHA-1062 for the treatment of mild-to-moderate Alzheimer's disease and completed an NDA filing to the FDA in September 2023. The company anticipates an FDA approval in mid-2024. The Company's ALPHA-1062 development program is primarily focused on clinical and regulatory development, Chemistry, Manufacturing and Control (CMC) development, and commercial readiness.

Alpha Cognition (XCNQ:ACOG) Headlines

No Headlines